Outside or inside: Role of the subcellular localization of DP4- Like enzymes for substrate conversion and inhibitor effects

Biological Chemistry

Volumn 392, Issue 3, 2011, Pages 169-187

  Bank, Ute ^a   Heimburg, Anke ^a   Wohlfarth, Astrid ^a   Koch, Gudrun ^a   Nordhoff, Karsten ^a   Julius, Heiko ^a   Helmuth, Martin ^a   Breyer, Doreen ^a   Reinhold, Dirk ^b   Täger, Michael ^a   Ansorge, Siegfried ^a  

^a IMTM GmbH   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

CD26; Dipeptidyl peptidase; Inhibitors; Lymphocytes; Neuropeptide Y (NPY); Substrates

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; DIPEPTIDYL PEPTIDASE IV INHIBITOR; NEUROPEPTIDE Y; DIPEPTIDASE; DIPEPTIDYL PEPTIDASE; DNA; DPP8 PROTEIN, HUMAN; DPP9 PROTEIN, HUMAN; DRUG DERIVATIVE; FLUORESCENT DYE; INDOLE DERIVATIVE; ISOLEUCINE; LYSINE; LYSYL (Z(NITRO))PYRROLIDIDE; LYSYL-(Z(NITRO))PYRROLIDIDE; PYRROLIDINE DERIVATIVE; UAMC00132;

ANIMAL CELL; ARTICLE; BIOTRANSFORMATION; CELL SURFACE; CELL VIABILITY; CONTROLLED STUDY; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; LEUKEMIA CELL LINE; LYMPHOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; CELL LINE; ENZYME SPECIFICITY; ENZYMOLOGY; GENETICS; INTRACELLULAR SPACE; METABOLISM; MOUSE MUTANT; T LYMPHOCYTE;

ANIMALS; CELL LINE; DIPEPTIDASES; DIPEPTIDYL PEPTIDASE 4; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; DIPEPTIDYL-PEPTIDASES AND TRIPEPTIDYL-PEPTIDASES; DNA; FLUORESCENT DYES; HUMANS; INDOLES; INTRACELLULAR SPACE; ISOLEUCINE; LYSINE; MICE; MICE, KNOCKOUT; NEUROPEPTIDE Y; PYRROLIDINES; SUBSTRATE SPECIFICITY; T-LYMPHOCYTES;

EID: 79953648964     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2011.025     Document Type: Article

References (81)

1. Abbott, C.A., Yu, D.M.,Woollatt, E., Sutherland, G.R., McCaughan, G.W., and Gorrell, M.D. (2000). Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8. Eur. J. Biochem. 267, 6140-6150.
2. Ajami, K., Abbott, C.A., McCaughan, G.W., and Gorrell, M.D. (2004). Dipeptidyl peptidase 9 has two forms, a broad tissue distribution, cytoplasmic localization and DP4-like peptidase activity. Biochim. Biophys. Acta 1679, 18-28. (Pubitemid 38881620)
3. Ansorge, S. and Reinhold, D. (2006). Immune peptides related to dipeptidyl aminopeptidase IV/CD26. In: Handbook of Biologically Active Peptides, A.J. Kastin, ed. (New York, USA: Elsevier/ Academic Press), pp. 567-572.
4. Ansorge, S., Nordhoff, K., Bank, U., Heimburg, A., Julius, H., Breyer, D., Thielitz, A., Reinhold, D., and Täger, M. (2011). Novel aspects of cellular action of dipeptidyl peptidase IV/ CD26. J. Biol. Chem. 392, (in press).
5. Assfalg-Machleidt, I., Rothe, G., Klingel, S., Banati, R., Mangel, W.F., Valet, G., and Machleidt, W. (1992). Membrane permeable fluorogenic rhodamine substrates for selective determination of cathepsin L. Biol. Chem. Hoppe-Seyler 373, 433-440.
6. Bank, U., Heimburg, A., Helmuth, M., Stefin, S., Lendeckel, U., Reinhold, D., Faust, J., Fuchs, P., Sens, B., Neubert, K., et al. (2006). Triggering endogenous immunosuppressive mechanisms by combined targeting of dipeptidyl peptidase IV (DPIV/CD26) and aminopeptidase N (APN/CD13) - a novel approach for the treatment of inflammatory bowel disease. Int. Immunopharmacol. 6, 1925-1934. (Pubitemid 44855708)
7. Bedoui, S., Kawamura, N., Straub, R.H., Pabst, R., Yamamura, T., and von Hörsten, S. (2003). Relevance of neuropeptide Y for the neuroimmune crosstalk. J. Neuroimmunol. 134, 1-11. (Pubitemid 36050825)
8. Bernstein, H.G., Schön, E., Ansorge, S., Röse, I., and Dorn, A. (1987). Immunolocalization of dipeptidyl aminopeptidase (DAP IV) in the developing human brain. Int. J. Dev. Neurosci. 5, 237-242.
9. Bjelke, J.R., Christensen, J., Nielsen, P.F., Branner, S., Kanstrup, A.B., Wagtmann, N., and Rasmussen, H.B. (2006). Dipeptidyl peptidases 8 and 9: Specificity and molecular characterization compared with dipeptidyl peptidase IV. Biochem. J. 396, 391-399. (Pubitemid 43837255)
10. Broemstrup, T. and Reuter, N. (2010). How does proteinase 3 interact with lipid bilayers? Phys. Chem. Chem. Phys. 12, 7487-7496.
11. Bühling, F., Kunz, D., Reinhold, D., Ulmer, A.J., Ernst, M., Flad, H.D., and Ansorge, S. (1994). Expression and functional role of dipeptidyl peptidase IV (CD26) on human natural killer cells. Nat. Immun. 13, 270-279. (Pubitemid 24326646)
12. Cen, H., Mao, F., Aronchik, I., Fuentes, R.J., and Firestone, G.L. (2008). DEVD-NucView488: A novel class of enzyme substrates for real-time detection of caspase-3 activity in live cells. FASEB J. 22, 2243-2252. (Pubitemid 351948643)
13. Chen, T., Ajami, K., McCaughan, G.W., Gorrell, M.D., and Abbott, C.A. (2003). Dipeptidyl peptidase IV gene family. The DP4 family. Adv. Exp. Med. Biol. 524, 79-86. (Pubitemid 36570813)
14. Chiravuri, M., Schmitz, T., Yardley, K., Underwood, R., Dayal, Y., and Huber, B.T. (1999). A novel apoptotic pathway in quiescent lymphocytes identified by inhibition of a post-proline cleaving aminodipeptidase: A candidate target protease, quiescent cell proline dipeptidase. J. Immunol. 163, 3092-3099. (Pubitemid 29431806)
15. Cordero, O.J., Salgano, F.J., Mera-Varela, A., and Nogueira, M. (2001). Serum interleukin-12, interleukin-15, soluble CD26, and adenosine deaminase in patients with rheumatoid arthritis. Rheumatol. Int. 21, 69-74. (Pubitemid 33036135)
16. Csernok, E., Lüdemann, J., Gross, W.L., and Bainton, D.F. (1990). Ultrastructural localization of proteinase 3, the target antigen of anti-cytoplasmic antibodies circulating in Wegener's granulomatosis. Am. J. Pathol. 137, 1113-1120.
17. Dalmasso, G., Charrier-Hisamuddin, L., Thu Nguyen, H.T., Yan, Y., Sitaraman, S., and Merlin, D. (2008). PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology 134, 166-178. (Pubitemid 350309324)
18. Deacon, C.F., Knudsen, L.B., Madsen, K., Wiberg, F.C., Jacobsen, O., and Holst, J.J. (1998). Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity. Diabetologia 41, 271-278. (Pubitemid 28254820)
19. De Meester, I., Korom, S., Van Damme, J., and Scharpé, S. (1999). CD26, let it cut or cut it down. Immunol. Today 20, 367-375. (Pubitemid 29356431)
20. Dubois, V., Van Ginneken, C., De Cock, H., Lambeir, A.M., Van der Veken, P., Augustyns, K., Chen, X., Scharpé, S., and De Meester, I. (2009). Enzyme activity and immunohistochemical localization of dipeptidyl peptidase 8 and 9 in male reproductive tissues. J. Histochem. Cytochem. 57, 531-541.
21. Dubois, V., Lambeir, A.M., Vandamme, S., Matheeussen, V., Guisez, Y., Scharpé, S., and De Meester, I. (2010). Dipeptidyl peptidase 9 (DPP9) from bovine testes: Identification and characterization as the short form by mass spectrometry. Biochim. Biophys. Acta 1804, 781-788.
22. Frerker, N., Wagner, L., Wolf, R., Heiser, U., Hoffmann, T., Rahfeld, J.U., Schade, J., Karl, T., Naim, H.Y., Alfalah, M., et al. (2007). Neuropeptide Y (NPY) cleaving enzymes: Structural and functional homologues of dipeptidyl peptidase 4. Peptides 28, 257-268. (Pubitemid 46188365)
23. Friedrich, D., Hoffmann, T., Bär, J., Wermann, M., Manhart, S., Heiser, U., and Demuth, H.U. (2007). Does human attractin have DP4 activity? Biol. Chem. 388, 155-162.
24. Geiss-Friedlander, R., Parmentier, N., Möller, U., Urlaub, H., Van den Eynde, B.J., and Melchior, F. (2009). The cytoplasmic peptidase DPP9 is rate-limiting for degradation of proline-containing peptides. J. Biol. Chem. 284, 27211-27219.
25. Ghersi, G., Chen, W., Lee, E.W., and Zukowska, Z. (2001). Critical role of dipeptidyl peptidase IV in neuropeptide Y-mediated endothelial cell migration in response to wounding. Peptides 22, 453-458. (Pubitemid 32250247)
26. Gorrell, M.D. (2005). Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders. Clin. Sci. (Lond.) 108, 277-292. (Pubitemid 40516992)
27. Haugland, R.P. (1995). Detecting enzymatic activity in cells using fluorogenic substrates. Biotech. Histochem. 70, 243-251.
28. Hildebrandt, M., Arck, P.C., Kruber, S., Demuth, H.U., Reutter, W., and Klapp, B.F. (2001). Inhibition of dipeptidyl peptidase IV (DP IV, CD26) activity abrogates stress-induced, cytokine-mediated murine abortions. Scand. J. Immunol. 53, 449-454. (Pubitemid 32382268)
29. Hoffmann, T., Faust, J., Neubert, K., and Ansorge, S. (1993). Dipeptidyl peptidase IV (CD 26) and aminopeptidase N (CD 13) catalyzed hydrolysis of cytokines and peptides with N-terminal cytokine sequences. FEBS Lett. 336, 61-64. (Pubitemid 23362003)
30. Hopsu-Havu, V.K. and Glenner, G.G. (1966). A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-b-naphthylamide. Histochemie 7, 197-201.
31. Hu, N., Westra, J., and Kallenberg, C.G. (2009). Membrane-bound proteinase 3 and its receptors: Relevance for the pathogenesis of Wegener's granulomatosis. Autoimmun. Rev. 8, 504-510.
32. Ishii, T., Ohnuma, K., Murakami, A., Takasawa, N., Kobayashi, S., Dang, N.H., Schlossman, S.F., and Morimoto, C. (2001). CD26- mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO. Proc. Natl. Acad. Sci. USA 98, 12138-12143. (Pubitemid 32959840)
33. Jungraithmayr, W., Oberreiter, B., De Meester, I., Wiedl, T., Inci, I., Bain, M., Augustyns, K., Hillinger, S., Scharpé, S., Weder, W., et al. (2009). The effect of organ-specific CD26/DPPIV enzymatic activity inhibitor-preconditioning on acute pulmonary allograft rejection. Transplantation 88, 478-485.
34. Kieffer, T.J., McIntosh, C.H., and Pederson, R.A. (1995). Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology 136, 3585-3596.
35. Kobayashi, S., Ohnuma, K., Uchiyama, M., Iino, K., Iwata, S., Dang, N.H., and Morimoto, C. (2004). Association of CD26 with CD45RA outside lipid rafts attenuates cord blood T-cell activation. Blood 103, 1002-1010. (Pubitemid 38129563)
36. Kuo, L.E., Abe, K., and Zukowska, Z. (2007). Stress, NPY and vascular remodeling: Implications for stress-related diseases. Peptides 28, 435-440. (Pubitemid 46176248)
37. Lankas, G.R., Leiting, B., Roy, R.S., Eiermann, G.J., Beconi, M.G., Biftu, T., Chan, C.C., Edmondson, S., Feeney, W.P., He, H., et al. (2005). Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: Potential importance of selectivity over dipeptidyl peptidases 8 and 9. Diabetes 54, 2988-2994. (Pubitemid 41401097)
38. Liu, Z., Christensson, M., Forslöw, A., De Meester, I., and Sundqvist, K.G. (2009). A CD26-controlled cell surface cascade for regulation of T cell motility and chemokine signals. J. Immunol. 183, 3616-3624.
39. Lorey, S., Faust, J., Bühling, F., Ansorge, S., and Neubert, K. (2000). A new type of fluorogenic substrates for determination of cellular dipeptidyl peptidase IV (DP IV/CD26) activity. Adv. Exp.Med. Biol. 477, 111-115. (Pubitemid 32173995)
40. Lorey, S., Faust, J., Mrestani-Klaus, C., Kähne, T., Ansorge, S., Neubert, K., and Bühling, F. (2002). Transcellular proteolysis demonstrated by novel cell surface-associated substrates of dipeptidyl peptidase IV (CD26). J. Biol. Chem. 277, 33170- 31777;
41. Erratum published in J. Biol. Chem. 277, 41294.
42. Maes, M.B., Lambeir, A.M., Gilany, K., Senten, K., Van der Veken, P., Leiting, B., Augustyns, K., Scharpé, S., and De Meester, I. (2005). Kinetic investigation of human dipeptidyl peptidase II (DPPII)-mediated hydrolysis of dipeptide derivatives and its identification as quiescent cell proline dipeptidase (QPP)/dipeptidyl peptidase 7 (DPP7). Biochem. J. 386, 315-324. (Pubitemid 40343789)
43. Maes, M.B., Dubois, V., Brandt, I., Lambeir, A.M., Van der Veken, P., Augustyns, K., Cheng, J.D., Chen, X., Scharpé, S., and De Meester, I. (2007). Dipeptidyl peptidase 8/9-like activity in human leukocytes. J. Leukoc. Biol. 81, 1252-1257. (Pubitemid 46702044)
44. Matteucci, E. and Giampietro, O. (2009). Dipeptidyl peptidase-4 (CD26): Knowing the function before inhibiting the enzyme. Curr. Med. Chem. 16, 2943-2951.
45. McDonald, J.K., Ellis, S., and Reilly, T.J. (1966). Properties of dipeptidyl arylamidase I of the pituitary. Chloride and sulfhydryl activation of seryltyrosyl-beta-naphthylamide hydrolysis. J. Biol. Chem. 241, 1494-1501.
46. McDonald, J.K., Reilly, T.J., Zeitman, B.B., and Ellis, S. (1968). Dipeptidyl arylamidase II of the pituitary. Properties of lysylalanyl- beta-naphthylamide hydrolysis: Inhibition by cations, distribution in tissues, and subcellular localization. J. Biol. Chem. 243, 2028-2037.
47. Marguet, D., Baggio, L., Kobayashi, T., Bernard, A.M., Pierres, M., Nielsen, P.F., Ribel, U., Watanabe, T., Drucker, D.J., and Wagtmann, N. (2000). Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26. Proc. Natl. Acad. Sci. USA 97, 6874-6879. (Pubitemid 30412807)
48. Mentlein, R. (1988). Proline residues in the maturation and degradation of peptide hormones and neuropeptides. FEBS Lett. 234, 251-256.
49. Movafagh, S., Hobson, J.P., Spiegel, S., Kleinman, H.K., and Zukowska, Z. (2006). Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors. FASEB J. 20, 1924-1926.
50. Niles, A.L., Moravec, R.A., Eric Hesselberth, P., Scurria, M.A., Daily, W.J., and Riss, T.L. (2007). A homogeneous assay to measure live and dead cells in the same sample by detecting different protease markers. Anal. Biochem. 366, 197-206. (Pubitemid 46898209)
51. O'Brien, M.A., Moravec, R.A., Riss, T.L., and Bulleit, R.F. (2008). Homogeneous, bioluminescent proteasome assays. Methods Mol. Biol. 414, 163-181.
52. Olsen, C. and Wagtmann, N. (2002). Identification and characterization of human DPP9, a novel homologue of dipeptidyl peptidase IV. Gene 299, 185-193. (Pubitemid 35379840)
53. Park, J.E., Lenter, M.C., Zimmermann, R.N., Garin-Chesa, P., Old, L.J., and Retting, W.J. (1999). Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. J. Biol. Chem. 274, 36505-36512.
54. Pospisilik, J.A., Stafford, S.G., Demuth, H.U., Brownsey, R., Parkhouse, W., Finegood, D.T., McIntosh, C.H., and Pederson, R.A. (2002). Long-term treatment with the dipeptidyl peptidase IV inhibitor P32/98 causes sustained improvements in glucose tolerance, insulin sensitivity, hyperinsulinemia, and beta-cell glucose responsiveness in VDF (fa/fa) Zucker rats. Diabetes 51, 943-950. (Pubitemid 34438335)
55. Preller, V., Gerber, A., Wrenger, S., Togni, M., Marguet, D., Tadje, J., Lendeckel, U., Röcken, C., Faust, J., Neubert, K., et al. (2007). TGF-b1-mediated control of central nervous system inflammation and autoimmunity through the inhibitory receptor CD26. J. Immunol. 178, 4632-4640. (Pubitemid 46492416)
56. Proost, P., Menten, P., Struyf, S., Schutyser, E., De Meester, I., and Van Damme, J. (2000). Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78beta into a most efficient monocyte attractant and CCR1 agonist. Blood 96, 1674-1680. (Pubitemid 30662110)
57. Reinhold, D., Bank, U., Bühling, F., Neubert, K., Mattern, T., Ulmer, A.J., Flad, H.D., and Ansorge, S. (1993). Dipeptidyl peptidase IV (CD26) on human lymphocytes. Synthetic inhibitors of and antibodies against dipeptidyl peptidase IV suppress the proliferation of pokeweed mitogen-stimulated peripheral blood mononuclear cells, and IL-2 and IL-6 production. Immunobiology 188, 403-414. (Pubitemid 23264757)
58. Reinhold, D., Bank, U., Bühling, F., Lendeckel, U., Faust, J., Neubert, K., and Ansorge, S. (1997a). Inhibitors of dipeptidyl peptidase IV induce secretion of transforming growth factor-beta 1 in PWM-stimulated PBMC and T cells. Immunology 91, 354-360. (Pubitemid 27304270)
59. Reinhold, D., Bank, U., Bühling, F., Täger, M., Born, I., Faust, J., Neubert, K., and Ansorge, S. (1997b). Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) induces secretion of transforming growth factor-beta 1 (TGF-b1) in stimulated mouse splenocytes and thymocytes. Immunol. Lett. 58, 29-35. (Pubitemid 27232383)
60. Reinhold, D., Biton, A., Goihl, A., Pieper, S., Lendeckel, U., Faust, J., Neubert, K., Bank, U., Täger, M., Ansorge, S., et al. (2007). Dual inhibition of dipeptidyl peptidase IV and aminopeptidase N suppresses inflammatory immune responses. Ann. N.Y. Acad.Sci. 1110, 402-409. (Pubitemid 350043029)
61. Riemann, D., Hansen, G.H., Niels-Christiansen, L., Thorsen, E., Immerdal, L., Santos, A.N., Kehlen, A., Langner, J., and Danielsen, E.M. (2001). Caveolae/lipid rafts in fibroblast-like synoviocytes: Ectopeptidase-rich membrane microdomains. Biochem. J. 354, 47-55. (Pubitemid 32183443)
62. Rothe, G., Klingel, S., Assfalg-Machleidt, I., Machleidt, W., Zirkelbach, C., Banati, R.B., Mangel, W.F., and Valet, G. (1992). Flow cytometric analysis of protease activities in vital cells. Biol. Chem. Hoppe Seyler 373, 547-554.
63. Ruoslahti, E. and Pierschbacher, M.D. (1987). New perspectives in cell adhesion: RGD and integrins. Science 238, 491-497. (Pubitemid 17147032)
64. Schön, E., Jahn, S., Kiessig, S.T., Demuth, H.U., Neubert, K., Barth, A., Von Baehr, R., and Ansorge, S. (1987). The role of dipeptidyl peptidase IV in human T lymphocyte activation. Inhibitors and antibodies against dipeptidyl peptidase IV suppress lymphocyte proliferation and immunoglobulin synthesis in vitro. Eur. J.Immunol. 17, 1821-1826. (Pubitemid 18052052)
65. Sedo, A. and Malík, R. (2001). Dipeptidyl peptidase IV-like molecules: Homologous proteins or homologous activities? Biochim. Biophys. Acta 1550, 107-116. (Pubitemid 34037997)
66. Sedo, A., Duke-Cohan, J.S., Balaziova, E., and Sedova, L.R. (2005). Dipeptidyl peptidase IV activity and/or structure homologs: Contributing factors in the pathogenesis of rheumatoid arthritis? Arthritis Res. Ther. 7, 253-269. (Pubitemid 41646256)
67. Steinbrecher, A., Reinhold, D., Quigley, L., Gado, A., Tresser, N., Izikson, L., Born, I., Faust, J., Neubert, K., Martin, R., et al. (2001). Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-b 1 secretion in vivo. J. Immunol. 166, 2041-2048. (Pubitemid 32114693)
68. Steinfeld, R., Fuhrmann, J.C., and Gärtner, J. (2006). Detection of tripeptidyl peptidase I activity in living cells by fluorogenic substrates.J. Histochem. Cytochem. 54, 991-996. (Pubitemid 44298585)
69. Tammen, H., Hess, R., Rose, H., Wienen, W., and Jost, M. (2008). Peptidomic analysis of blood plasma after in vivo treatment with protease inhibitors - a proof of concept study. Peptides 29, 2188-2195. (Pubitemid 50291022)
70. Tanaka, S., Murakami, T., Horikawa, H., Sugiura, M., Kawashima, K., and Sugita, T. (1997). Suppression of arthritis by the inhibitors of dipeptidyl peptidase IV. Int. J. Immunopharmacol. 19, 15-24. (Pubitemid 27259665)
71. Tang, H.K., Tang, H.Y., Hsu, S.C., Chu, Y.R., Chien, C.H., Shu, C.H., and Chen, X. (2009). Biochemical properties and expression profile of human prolyl dipeptidase DPP9. Arch. Biochem. Biophys. 485, 120-127.
72. Van Damme, J., Struyf, S., Wuyts, A., Van Coillie, E., Menten, P., Schols, D., Sozzani, S., De Meester, I., and Proost, P. (1999). The role of CD26/DPP IV in chemokine processing. Chem. Immunol. 72, 42-56. (Pubitemid 29403343)
73. Vanhoof, G., Goossens, F., De Meester, I., Hendriks, D., and Scharpé, S. (1995). Proline motifs in peptides and their biological processing. FASEB J. 9, 736-744.
74. Von Vietinghoff, S., Tunnemann, G., Eulenberg, C., Wellner, M., Cristina Cardoso, M., Luft, F.C., and Kettritz, R. (2007). NB1 mediates surface expression of the ANCA antigen proteinase 3 on human neutrophils. Blood 109, 4487-4493. (Pubitemid 46743419)
75. Wheway, J., Mackay, C.R., Newton, R.A., Sainsbury, A., Boey, D., Herzog, H., and Mackay, F. (2005). A fundamental bimodal role for neuropeptide Y1 receptor in the immune system. J. Exp. Med. 202, 1527-1538. (Pubitemid 41746599)
76. Witko-Sarsat, V., Reuter, N., and Mouthon, L. (2010). Interaction of proteinase 3 with its associated partners: Implications in the pathogenesis of Wegener's granulomatosis. Curr. Opin. Rheumatol. 22, 1-7.
77. Wrenger, S., Faust, J., Friedrich, D., Hoffmann, T., Hartig, R., Lendeckel, U., Kähne, T., Thielitz, A., Neubert, K., and Reinhold, D. (2006). Attractin, a dipeptidyl peptidase IV/CD26-like enzyme, is expressed on human peripheral blood monocytes and potentially influences monocyte function. J. Leukoc. Biol. 80, 621-629. (Pubitemid 44835796)
78. Wu, J.J., Tang, H.K., Yeh, T.K., Chen, C.M., Shy, H.S., Chu, Y.R., Chien, C.H., Tsai, T.Y., Huang, Y.C., Huang, Y.L., et al. (2009). Biochemistry, pharmacokinetics, and toxicology of a potent and selective DPP8/9 inhibitor. Biochem. Pharmacol. 78, 203-210.
79. Yan, S., Marguet, D., Dobers, J., Reutter, W., and Fan, H. (2003).Deficiency of CD26 results in a change of cytokine and immunoglobulin secretion after stimulation by pokeweed mitogen. Eur. J. Immunol. 33, 1519-1527. (Pubitemid 36790412)
80. Yazbeck, R., Howarth, G.S., and Abbott, C.A. (2009). Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease? Trends Pharmacol. Sci. 30, 600-607.
81. Zukowska, Z., Pons, J., Lee, E.W., and Li, L. (2003). Neuropeptide Y: A new mediator linking sympathetic nerves, blood vessels and immune system? Can. J. Physiol. Pharmacol. 81, 89-94. (Pubitemid 36398880)